About Ramelteon API

CH₃ H₃C-O N
Therapeutic Category CNS Depressant
CAS Number 196597-26-9
API Technology Novel API Development
Dose Form Tablets / Capsules
Synergene's Development Status Under Development
Available Regulatory Filing Under Validation / Process Optimization

Mechanism of Action

Ramelteon is currently under laboratory validation and pilot process optimization for CNS Depressant therapy.

Target Indication

Under development for CNS Depressant indications. Scale-up batches in progress.